Results 71 to 80 of about 674,474 (173)

Poster Session 4

open access: yes
Pregnancy, Volume 2, Issue S2, September 2026.
wiley   +2 more sources

Progressive familial intrahepatic cholestasis and benign recurrent intrahepatic cholestasis : a review

open access: yes, 2012
Progressive familial intrahepatic cholestasis (PFIC) and benign recurrent intrahepatic cholestasis (BRIC) are two rare autosomal recessive disorders, characterized by cholestasis.
STRUBBE, BEATRIJS   +3 more
core  

Case Report: Mild BRIC-like cholestasis despite a gross USP53 deletion—novel findings and literature review

open access: yesFrontiers in Genetics
We report a pediatric case of cholestatic liver disease associated with two novel compound heterozygous variants in the USP53 gene: a truncating c.1219A>T (p.Lys407*) variant inherited from the father and a maternally inherited gross deletion ...
Ekaterina Nuzhnaya   +10 more
doaj   +1 more source

Benign Recurrent Intrahepatic Cholestasis [PDF]

open access: yesJournal of the Royal Society of Medicine, 1985
N J, Wareham   +2 more
openaire   +2 more sources

ATP8B1 gene expression is driven by a housekeeping-like promoter independent of bile acids and farnesoid X receptor.

open access: yesPLoS ONE, 2012
BackgroundMutations in ATP8B1 gene were identified as a cause of low γ-glutamyltranspeptidase cholestasis with variable phenotype, ranging from Progressive Familial Intrahepatic Cholestasis to Benign Recurrent Intrahepatic Cholestasis.
Dita Cebecauerová   +4 more
doaj   +1 more source

Intractable cough and abnormal pulmonary function in benign recurrent intrahepatic cholestasis

open access: yes, 2019
Benign recurrent intrahepatic cholestasis (BRIC) is a syndrome characterized by recurrent episodes of cholestasis with associated pruritus. The intensity and duration of cholestatic episodes, and the length of the intervening periods, vary. unpredictably.
Lagarde, S.   +3 more
core   +1 more source

A Physiology-Based Model of Human Bile Acid Metabolism for Predicting Bile Acid Tissue Levels After Drug Administration in Healthy Subjects and BRIC Type 2 Patients

open access: yesFrontiers in Physiology, 2019
Drug-induced liver injury (DILI) is a matter of concern in the course of drug development and patient safety, often leading to discontinuation of drug-development programs or early withdrawal of drugs from market. Hepatocellular toxicity or impairment of
Vanessa Baier   +7 more
doaj   +1 more source

Mild intrahepatic cholestasis of pregnancy—A call to redefine diagnostic criteria and consider a new management paradigm

open access: yes
Pregnancy, Volume 2, Issue 1, January 2026.
Minhazur Sarker   +9 more
wiley   +1 more source

Benign recurrent intrahepatic cholestasis: A long‐term follow‐up study of two patients

open access: yes, 1989
Two brothers with benign recurrent intrahepatic cholestasis were studied over a period of 6 years. During this period, 11 episodes of cholestasis were observed, with a mean duration of 2.6 months (range: 2 weeks to 6 months).
Kuipers, F; id_orcid   +5 more
core   +1 more source

The prevalence and pregnancy outcomes of intrahepatic cholestasis of pregnancy: a retrospective clinical audit review

open access: yes, 2018
Background To determine the prevalence and outcomes of intrahepatic cholestasis of pregnancy. Methods A review comparing intrahepatic cholestasis of pregnancy pregnancies to all other pregnancies in three tertiary care Australian hospitals over a 36 ...
Morton, Adam   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy